Sako et al., In Vivo 2005
(Adenocarcinoma...) :
TAC-101 did not affect the expression of Fas ligand, but obviously increased the expression of Fas in the metastatic tumors
Inoue et al., In Vivo 2007
(Colonic Neoplasms) :
Although TAC-101 did not change the expression of TNF-R1 and DR3, TAC-101 increased the expression of Fas in both a time- and a dose dependent manner